{
    "id": "article-001",
    "title": "How to treat a superficial vein thrombosis of the lower extremity veins if the patient has intermediate risk of VTE?",
    "content": [
        {
            "type": "section",
            "content": [
                {
                    "type": "heading",
                    "level": 2,
                    "content": {
                        "type": "string",
                        "content": "Short answer"
                    }
                },
                {
                    "type": "paragraph",
                    "content": [
                        {
                            "type": "string",
                            "content": "If superficial vein thrombosis involves an axial lower‑limb superficial vein segment ≥ 5 cm or lies 3–5 cm from a deep‑vein junction and no additional venous thrombo‑embolism risk factors are present, then start prophylactic‑dose anticoagulation for 45 days:"
                        },
                        {
                            "type": "list",
                            "order": "unordered",
                            "content": [
                                {
                                    "index": 1,
                                    "content": {
                                        "type": "string",
                                        "content": "fondaparinux 2.5 mg subcutaneously once daily"
                                    }
                                },
                                {
                                    "index": 2,
                                    "content": {
                                        "type": "string",
                                        "content": "or low‑molecular‑weight heparin (dalteparin 5 000 IU subcutaneously every 12 h or enoxaparin 40 mg subcutaneously once daily)"
                                    }
                                },
                                {
                                    "index": 3,
                                    "content": {
                                        "type": "string",
                                        "content": "or rivaroxaban 10 mg orally once daily"
                                    }
                                }
                            ]
                        },
                        {
                            "type": "string",
                            "content": "If pain, oedema or erythema persist, also apply class II compression stocking, limb elevation, and cool or warm compresses (avoid non‑steroidal anti‑inflammatory drugs once anticoagulation begins)."
                        },
                        {
                            "type": "string",
                            "content": "If thrombus propagates (< 3 cm from deep system) or patient carries medical venous thrombo‑embolism risk factors, then switch to full‑dose therapeutic anticoagulation for 3 months."
                        }
                    ]
                }
            ]
        },
        {
            "type": "section",
            "content": [
                {
                    "type": "heading",
                    "level": 2,
                    "content": {
                        "type": "string",
                        "content": "contextual_answer"
                    }
                },
                {
                    "type": "heading",
                    "level": 3,
                    "content": {
                        "type": "string",
                        "content": "1 Epidemiology and pathophysiology"
                    }
                },
                {
                    "type": "paragraph",
                    "content": [
                        {
                            "type": "string",
                            "content": "Superficial vein thrombosis of axial veins is more frequent than deep‑vein thrombosis and carries an early risk of deep‑vein thrombosis or pulmonary embolism."
                        },
                        {
                            "type": "string",
                            "content": "Risk rises when thrombus is ≥ 5 cm or approaches the saphenofemoral or saphenopopliteal junctions."
                        }
                    ]
                },
                {
                    "type": "heading",
                    "level": 3,
                    "content": {
                        "type": "string",
                        "content": "2 Clinical risk stratification for venous thrombo‑embolism"
                    }
                },
                {
                    "type": "table",
                    "content": [
                        {
                            "index": 1,
                            "content": {
                                "type": "array",
                                "items": [
                                    {
                                        "type": "string",
                                        "content": "Category"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Criteria"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Immediate thrombo‑embolism risk"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Initial treatment"
                                    }
                                ]
                            }
                        },
                        {
                            "index": 2,
                            "content": {
                                "type": "array",
                                "items": [
                                    {
                                        "type": "string",
                                        "content": "Low"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Axial segment ≤ 5 cm and > 5 cm from deep system"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Low"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Supportive care only"
                                    }
                                ]
                            }
                        },
                        {
                            "index": 3,
                            "content": {
                                "type": "array",
                                "items": [
                                    {
                                        "type": "string",
                                        "content": "Intermediate"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Axial segment ≥ 5 cm or 3–5 cm from deep system, no additional medical risk factors"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Moderate"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Prophylactic‑dose anticoagulation 45 days"
                                    }
                                ]
                            }
                        },
                        {
                            "index": 4,
                            "content": {
                                "type": "array",
                                "items": [
                                    {
                                        "type": "string",
                                        "content": "High"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Thrombus < 3 cm from deep system, propagation despite prophylaxis, recurrence, or concomitant medical risk factors (previous deep‑vein thrombosis, thrombophilia, cancer)"
                                    },
                                    {
                                        "type": "string",
                                        "content": "High"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Therapeutic‑dose anticoagulation 3 months"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "type": "heading",
                    "level": 3,
                    "content": {
                        "type": "string",
                        "content": "3 Diagnostic algorithm (decision‑tree)"
                    }
                },
                {
                    "type": "paragraph",
                    "content": [
                        {
                            "type": "string",
                            "content": "Suspected superficial vein thrombosis → duplex ultrasound of superficial and deep systems."
                        },
                        {
                            "type": "string",
                            "content": "If axial superficial vein thrombosis confirmed, measure length and distance from junctions and assign risk category as above."
                        },
                        {
                            "type": "string",
                            "content": "If tributary‑only thrombosis → supportive care, follow‑up ultrasound if symptoms progress."
                        }
                    ]
                },
                {
                    "type": "heading",
                    "level": 3,
                    "content": {
                        "type": "string",
                        "content": "4 Treatment of intermediate‑risk superficial vein thrombosis"
                    }
                },
                {
                    "type": "paragraph",
                    "content": [
                        {
                            "type": "string",
                            "content": "Exact schemes"
                        }
                    ]
                },
                {
                    "type": "table",
                    "content": [
                        {
                            "index": 1,
                            "content": {
                                "type": "array",
                                "items": [
                                    {
                                        "type": "string",
                                        "content": "Drug"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Dose"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Route"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Frequency"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Duration"
                                    }
                                ]
                            }
                        },
                        {
                            "index": 2,
                            "content": {
                                "type": "array",
                                "items": [
                                    {
                                        "type": "string",
                                        "content": "Fondaparinux"
                                    },
                                    {
                                        "type": "string",
                                        "content": "2.5 mg"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Subcutaneous"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Once daily"
                                    },
                                    {
                                        "type": "string",
                                        "content": "45 days"
                                    }
                                ]
                            }
                        },
                        {
                            "index": 3,
                            "content": {
                                "type": "array",
                                "items": [
                                    {
                                        "type": "string",
                                        "content": "Dalteparin"
                                    },
                                    {
                                        "type": "string",
                                        "content": "5 000 international units"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Subcutaneous"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Every 12 hours"
                                    },
                                    {
                                        "type": "string",
                                        "content": "45 days"
                                    }
                                ]
                            }
                        },
                        {
                            "index": 4,
                            "content": {
                                "type": "array",
                                "items": [
                                    {
                                        "type": "string",
                                        "content": "Enoxaparin"
                                    },
                                    {
                                        "type": "string",
                                        "content": "40 mg"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Subcutaneous"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Once daily"
                                    },
                                    {
                                        "type": "string",
                                        "content": "45 days"
                                    }
                                ]
                            }
                        },
                        {
                            "index": 5,
                            "content": {
                                "type": "array",
                                "items": [
                                    {
                                        "type": "string",
                                        "content": "Rivaroxaban"
                                    },
                                    {
                                        "type": "string",
                                        "content": "10 mg"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Oral"
                                    },
                                    {
                                        "type": "string",
                                        "content": "Once daily"
                                    },
                                    {
                                        "type": "string",
                                        "content": "45 days"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "type": "heading",
                    "level": 3,
                    "content": {
                        "type": "string",
                        "content": "Supportive measures"
                    }
                },
                {
                    "type": "paragraph",
                    "content": [
                        {
                            "type": "string",
                            "content": "Class II or higher graduated compression stocking covering thrombosed segment."
                        },
                        {
                            "type": "string",
                            "content": "Limb elevation to waist level."
                        },
                        {
                            "type": "string",
                            "content": "Cool or warm compresses as tolerated."
                        },
                        {
                            "type": "string",
                            "content": "Avoid non‑steroidal anti‑inflammatory drugs once anticoagulation is started to limit bleeding risk."
                        }
                    ]
                },
                {
                    "type": "heading",
                    "level": 3,
                    "content": {
                        "type": "string",
                        "content": "5 Follow‑up"
                    }
                },
                {
                    "type": "paragraph",
                    "content": [
                        {
                            "type": "string",
                            "content": "Reassess clinically at 7–10 days; repeat duplex ultrasound if pain, erythema or cord length increase."
                        },
                        {
                            "type": "string",
                            "content": "At day 45 obtain D‑dimer; persistent elevation suggests residual thrombus and may justify extended prophylaxis."
                        }
                    ]
                },
                {
                    "type": "heading",
                    "level": 3,
                    "content": {
                        "type": "string",
                        "content": "6 Prognosis"
                    }
                },
                {
                    "type": "paragraph",
                    "content": [
                        {
                            "type": "string",
                            "content": "With the above regimen the incidence of thrombo‑embolic complications at 47 days falls from ≈ 6 % to < 1 %."
                        },
                        {
                            "type": "string",
                            "content": "Recurrence risk rises if anticoagulation is stopped early; full 45‑day course is therefore recommended."
                        }
                    ]
                }
            ]
        }
    ],
    "metadata": {
        "authors": [
            {
                "id": "author-001",
                "name": "Author Name"
            }
        ],
        "createdOn": "2023-10-20",
        "tags": [
            "thrombosis",
            "VTE",
            "treatment",
            "guidelines"
        ]
    }
}